Cannabis use has become common enough that anesthesiologists increasingly encounter patients who smoke marijuana, use THC edibles, vape cannabis concentrates, take CBD products, or use prescription cannabinoid medications before surgery. For many patients, marijuana may seem unrelated to anesthesia, especially when it is used regularly without obvious problems. From an anesthesiology perspective, however, cannabis can influence the brain, cardiovascular system, lungs, pain pathways, and the way the body responds to sedatives and anesthetic drugs. The timing of the last dose, frequency of use, THC concentration, route of administration, and whether the person is acutely intoxicated can all affect perioperative decisions.
The scientific picture is still developing, and many commonly repeated rules about marijuana before surgery are based on limited evidence rather than large randomized trials. Nevertheless, enough research now exists for major organizations—including the American Society of Regional Anesthesia and Pain Medicine (ASRA), the American Society of Anesthesiologists (ASA), and the American College of Surgeons—to recommend that cannabis use be disclosed before anesthesia. A major 2023 ASRA consensus guideline concluded that surgical patients using cannabinoids may face increased perioperative risks and recommended universal screening for cannabis use before procedures requiring anesthesia.
Why Cannabis Matters to Anesthesiologists
General anesthesia is carefully adjusted to keep a patient unconscious, free of pain, physiologically stable, and safely ventilated throughout an operation. Sedation for procedures such as colonoscopy, dental surgery, or endoscopy uses many of the same medications at different doses. Cannabis becomes relevant because THC affects cannabinoid receptors throughout the central nervous system and can alter consciousness, memory, anxiety, heart rate, blood pressure, pain perception, and responses to other psychoactive drugs. Chronic use can also produce tolerance and adaptive changes in the nervous system that may influence how much anesthetic is needed.
For this reason, ASRA recommends that clinicians ask about the type of cannabis product being used, the route of administration, the amount, frequency, and the time of the most recent dose. Routine urine testing for cannabinoids is not recommended for every surgical patient because a positive THC metabolite test does not reveal whether someone is currently intoxicated or when cannabis was last consumed. What matters more clinically is an accurate history. ASA patient guidance similarly emphasizes that anesthesiologists need this information to anticipate possible changes in anesthetic requirements, cardiovascular and respiratory risks, postoperative pain, nausea, drug interactions, and withdrawal.
Cannabis Users May Need Different Amounts of Anesthesia
One of the most studied questions is whether regular marijuana users require more propofol, a powerful intravenous anesthetic commonly used for general anesthesia and procedural sedation. A 2009 prospective study from Lund University Hospital compared frequent cannabis users with nonusers undergoing anesthesia. Although the amount of propofol required to reach a specific brain-monitoring target did not differ substantially, regular cannabis users required significantly more propofol for satisfactory insertion of a laryngeal mask airway—an average of about 314 milligrams compared with 263 milligrams among nonusers.
Later research has strengthened the overall association. A 2025 meta-analysis led by investigators from Boston University and the University of Vermont evaluated eight studies involving 2,268 patients. Cannabis users received an average of about 47 milligrams more propofol than nonusers. The estimated difference was roughly 31 milligrams during general anesthesia and 53 milligrams during endoscopic sedation. The investigators cautioned that studies differed substantially in their methods and definitions of cannabis use, meaning these figures should not be interpreted as universal dose adjustments. Still, the direction of the association was consistent enough to support individualized anesthetic management.
New Research Suggests the Difference May Be Real but Modest
An especially large study published online in the British Journal of Anaesthesia in September 2026 adds important perspective. Researchers affiliated with Harvard Medical School and Beth Israel Deaconess Medical Center examined more than 341,000 adults receiving propofol sedation or inhaled general anesthesia between 2008 and 2024. Nearly 24,000 were identified as non-medical cannabis users, while more than 3,000 had medical-cannabinoid certification. Both groups received statistically higher doses of propofol and slightly higher concentrations of inhaled anesthetic agents than people without documented cannabis use.
The differences, however, were smaller than some earlier studies suggested. Daily recreational users showed the strongest association with increased propofol dosing, while the increase in volatile anesthetic requirements was relatively modest. This distinction is important. Current research does not show that every cannabis user automatically requires dramatically more anesthesia. Acute intoxication may even have different effects from chronic tolerance. ASRA concluded that acutely intoxicated users might sometimes require less anesthetic, whereas long-term regular users who are not intoxicated may require more. Anesthesiologists therefore adjust medication according to the patient’s clinical condition rather than applying a single marijuana-based formula.
Cannabis, Heart Rate, Blood Pressure, and Surgical Risk
THC can acutely affect the cardiovascular system. Cannabis smoking commonly increases heart rate and may raise blood pressure shortly after use, while higher doses can sometimes produce lower blood pressure, dizziness, or orthostatic symptoms. These changes matter during anesthesia because anesthetic drugs themselves alter heart rate, vascular tone, and blood pressure. ASRA concluded with high certainty that smoking cannabis can produce significant increases in heart rate and blood pressure during the first one to two hours after use and found moderate evidence of a temporarily increased risk of perioperative myocardial infarction during this period.
Large observational studies also raise concerns about heavier patterns of use. A University of Texas Health Science Center study published in JAMA Surgery evaluated 12,422 matched hospitalizations involving major elective surgery. Patients with diagnosed cannabis use disorder experienced a composite of serious perioperative complications or mortality in 7.73 percent of cases compared with 6.57 percent among matched patients without cannabis use disorder, corresponding to a modest but statistically significant increase in risk. These data apply to cannabis use disorder rather than occasional use, and observational studies cannot prove that marijuana directly caused the complications, but they reinforce the importance of identifying frequent or problematic use before surgery.
Smoking Cannabis Can Affect the Airway
The method of cannabis use also matters. Marijuana smoke contains heated particles and combustion products capable of irritating the mouth, throat, bronchi, and lungs. Chronic smokers may experience cough, wheezing, increased airway secretions, and bronchitis-like symptoms. These changes can complicate anesthesia because an anesthesiologist may need to place a breathing tube or another airway device while the patient is unconscious. The American College of Surgeons warns that marijuana smoking can make airway management more difficult and increase respiratory concerns around surgery.
Rare acute airway reactions have also been documented. Stanford University physicians reported a case involving a healthy teenager who inhaled marijuana shortly before general anesthesia and later developed severe swelling of the uvula that obstructed his airway during recovery. Such cases are uncommon and should not be interpreted as an expected reaction to marijuana, but they illustrate why anesthesiologists care about very recent smoking even when a patient otherwise appears healthy. Vaping may avoid traditional smoke combustion, but inhaled aerosols can still irritate the airway, and the perioperative safety of high-potency cannabis vaping has not been characterized nearly as well as clinicians would like.
Cannabis Does Not Necessarily Reduce Pain After Surgery
A common assumption is that because cannabis can be used for chronic pain, people who use it before surgery should require fewer opioid medications afterward. Current evidence does not support that conclusion consistently. ASRA’s guideline found evidence that habitual cannabis users may actually experience greater postoperative pain and require more opioids. Acute postoperative pain is biologically different from many chronic-pain conditions, and tolerance to cannabinoids or changes in pain sensitivity may influence how regular users respond following an operation.
A large Cleveland Clinic study published in Anesthesia & Analgesia examined 34,521 adults having elective surgery, including 1,683 who had used cannabis within the previous 30 days. After statistical adjustment, cannabis users consumed approximately 30 percent more opioids during the first 24 hours following surgery than nonusers. They also reported somewhat greater pain. This does not mean every cannabis user will need substantially more opioid medication, but it challenges the idea that preoperative marijuana reliably functions as an opioid-sparing treatment. Multimodal pain control using non-opioid medications, regional anesthesia, nerve blocks, and other strategies may therefore be particularly valuable for frequent cannabis users.
Cannabis and Postoperative Nausea
Cannabis is sometimes used to reduce nausea, leading to another seemingly logical assumption: cannabis users should experience less nausea after anesthesia. A large University of Washington study found the opposite. Investigators examined more than 27,000 patients undergoing general anesthesia and estimated that daily cannabis use was associated with approximately a 19 percent relative increase in postoperative nausea and vomiting, corresponding to an absolute increase of roughly 3.3 percentage points. Less frequent cannabis use showed a weaker association.
The effect is not enormous, but it is clinically relevant because postoperative nausea and vomiting are among the most unpleasant complications of anesthesia. Heavy long-term cannabis users can also develop cannabinoid hyperemesis syndrome, a separate condition characterized by recurrent episodes of severe nausea and vomiting. An anesthesiologist who knows that a patient regularly consumes THC can take cannabis use into account alongside established nausea risk factors and may adjust anti-nausea prevention accordingly.
How Long Should Cannabis Be Avoided Before Anesthesia?
There is no scientifically established abstinence period that applies perfectly to every cannabis product and every patient. ASRA’s consensus guideline recommends delaying elective surgery for at least two hours after cannabis smoking because cardiovascular effects and myocardial-infarction risk are greatest shortly after inhalation. Elective procedures should also be postponed whenever acute cannabis intoxication has impaired cognition or the patient’s ability to give informed consent. Importantly, the two-hour recommendation is a minimum delay rather than a declaration that smoking cannabis two hours and one minute before anesthesia is risk-free.
Other organizations use more conservative advice. The American College of Surgeons advises avoiding marijuana products for approximately 72 hours before general anesthesia. Reviews cited by ASRA have suggested intervals ranging from 72 hours to substantially longer for certain oral cannabinoid products, but ASRA concluded that the available research is insufficient to mandate one universal cessation period. The safest practical approach is to follow the instructions given by the patient’s anesthesiologist or surgical team rather than attempting to calculate an abstinence period independently. People using prescription cannabinoid medications for a medical condition should discuss discontinuation with their physician instead of abruptly stopping treatment.
Edibles, CBD, and Medical Cannabis Still Matter
Avoiding smoke does not eliminate all anesthesia considerations. Edibles can deliver substantial amounts of THC and may cause psychoactive and cardiovascular effects for considerably longer than inhaled marijuana because oral THC is absorbed slowly and metabolized into active compounds before reaching systemic circulation. High-dose concentrates can likewise produce prolonged intoxication. ASRA states that there is not enough evidence to specify a precise waiting period for every non-smoked cannabis formulation, so clinicians must consider dose, route, timing, and the individual patient’s condition.
CBD is less intoxicating than THC but should still be reported before surgery. Cannabidiol can interact with liver enzymes responsible for processing medications and is not pharmacologically inert. At the same time, abruptly discontinuing certain prescription cannabinoid drugs may be inappropriate. ASA guidance specifically notes that medications such as dronabinol, nabilone, or the FDA-approved CBD medicine Epidiolex may need to be continued depending on the clinical situation. The important distinction is that medically supervised cannabinoid treatment can be incorporated into the anesthetic plan, whereas undisclosed use leaves the anesthesia team without information needed to anticipate possible interactions.
Cannabis Withdrawal After Surgery
Frequent cannabis users can develop withdrawal when regular THC exposure suddenly stops. Symptoms may include irritability, nervousness, restlessness, sleep disturbance, decreased appetite, mood changes, sweating, chills, abdominal discomfort, or headache. Because hospitalized surgical patients cannot usually continue recreational marijuana use, withdrawal can begin during recovery and may be mistaken for ordinary postoperative anxiety, insomnia, or pain.
ASRA specifically recommends considering cannabis withdrawal in habitual users after surgery. The highest risk appears to occur among people consuming large or uncertain quantities of THC-containing products, while CBD-dominant products carry much less withdrawal risk. Severe cases can be managed medically, but prevention begins with an accurate preoperative history. Someone who uses cannabis every night, for example, provides clinically important information even if the product is legal and the patient does not consider it a drug.
Final Thoughts on Cannabis and Anesthesia
Cannabis does not make anesthesia automatically unsafe, and millions of cannabis users undergo surgery successfully. What research increasingly shows is that medical marijuana use can change the variables anesthesiologists need to manage. Regular users may require somewhat higher doses of propofol or inhaled anesthetics, especially with frequent use. Recent smoking can increase heart rate and blood pressure and may irritate the airway. Habitual users may experience greater postoperative pain, use more opioids, and have a slightly increased risk of postoperative nausea. Patients with cannabis use disorder may also face higher rates of serious perioperative complications.
The most important step is therefore simple: tell the anesthesiologist what cannabis products are being used, how they are taken, approximately how much is consumed, how frequently they are used, and when the last dose occurred. ASRA’s guidelines recommend this screening for every surgical patient because cannabis exposure can influence decisions before, during, and after anesthesia. Patients should not arrive for elective surgery acutely intoxicated, and smoking on the day of surgery is strongly discouraged. Beyond that, there is no single abstinence rule appropriate for every THC edible, CBD preparation, medical cannabinoid, or pattern of use. An individualized anesthetic plan remains the safest way to account for a rapidly evolving area of cannabis medicine.
